CR8700A - Hormonas humanas de glicoproteinas superagonistas y sus usos - Google Patents

Hormonas humanas de glicoproteinas superagonistas y sus usos

Info

Publication number
CR8700A
CR8700A CR8700A CR8700A CR8700A CR 8700 A CR8700 A CR 8700A CR 8700 A CR8700 A CR 8700A CR 8700 A CR8700 A CR 8700A CR 8700 A CR8700 A CR 8700A
Authority
CR
Costa Rica
Prior art keywords
glicoproteins
superagonist
hormones
human hormones
human
Prior art date
Application number
CR8700A
Other languages
English (en)
Inventor
W Szkudlinski Mariusz
D Weintraub Bruce
Original Assignee
Trophogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophogen Inc filed Critical Trophogen Inc
Publication of CR8700A publication Critical patent/CR8700A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion proporciona los metodos mejorados para la formacion de imagenes, la terapia dirigida y la deteccion de diagnostico utilizando hormonas glucoproteicas modificadas que tiene actividad incrementada sobre las hormonas de tipo silvestre.
CR8700A 2004-03-31 2006-10-20 Hormonas humanas de glicoproteinas superagonistas y sus usos CR8700A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55770404P 2004-03-31 2004-03-31

Publications (1)

Publication Number Publication Date
CR8700A true CR8700A (es) 2007-07-19

Family

ID=35150595

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8700A CR8700A (es) 2004-03-31 2006-10-20 Hormonas humanas de glicoproteinas superagonistas y sus usos

Country Status (13)

Country Link
US (1) US20090214424A1 (es)
EP (1) EP1738174A2 (es)
JP (1) JP2007530974A (es)
KR (1) KR20070026493A (es)
CN (1) CN1965234A (es)
AU (1) AU2005233923A1 (es)
BR (1) BRPI0509469A (es)
CA (1) CA2561545A1 (es)
CR (1) CR8700A (es)
IL (1) IL178389A0 (es)
MX (1) MXPA06011290A (es)
RU (1) RU2006138235A (es)
WO (1) WO2005101000A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101246176B (zh) * 2007-02-13 2013-06-05 许洋 鳞状细胞癌抗原阴性宫颈癌血清蛋白质检测的质谱试剂及其制备方法
CN102372780A (zh) * 2010-08-23 2012-03-14 上海市计划生育科学研究所 抗人绒毛膜促性腺激素抗体-白介素2融合蛋白的制备及其应用
CN102847151B (zh) * 2011-07-01 2014-08-13 天津金耀集团有限公司 含有巯乙基磺酸钠和糖皮质激素的吸入制剂及其制备方法
JP6429774B2 (ja) 2012-07-30 2018-11-28 トロホジェン・インコーポレーテッド 糖タンパク質ホルモン長期作用性スーパーアゴニスト
MX2015001912A (es) * 2012-08-21 2015-06-05 Repros Therapeutics Inc Formulaciones de trans - clomifeno y usos de las mismas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326467B1 (en) * 1989-02-23 2001-12-04 Colorado State University Research Foundation Hormone-recombinant toxin compounds and methods for using same
EP0517829B2 (en) * 1990-03-02 2007-12-26 Boston Medical Center Corporation Improved chimeric toxins
EP1947117B1 (en) * 1996-05-08 2013-07-17 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Glycoprotein hormone superagonists
US6361992B1 (en) * 1996-05-08 2002-03-26 The United States Of America As Represented By The Department Of Health And Human Services Thyroid stimulating hormone superagonists
KR100642586B1 (ko) * 1997-09-22 2006-11-10 유니버시티 어브 메릴랜드, 발티모어 갑상선 자극 호르몬의 변이체 및 이에 근거한 방법
EP1115866A1 (en) * 1998-09-22 2001-07-18 University of Maryland at Baltimore Cystine knot growth factor mutants

Also Published As

Publication number Publication date
RU2006138235A (ru) 2008-05-10
CA2561545A1 (en) 2005-10-27
KR20070026493A (ko) 2007-03-08
AU2005233923A1 (en) 2005-10-27
IL178389A0 (en) 2007-02-11
US20090214424A1 (en) 2009-08-27
BRPI0509469A (pt) 2007-09-11
WO2005101000A2 (en) 2005-10-27
CN1965234A (zh) 2007-05-16
JP2007530974A (ja) 2007-11-01
EP1738174A2 (en) 2007-01-03
MXPA06011290A (es) 2007-03-21
WO2005101000A3 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
CR11017A (es) Anticuerpos anti-robo4 y sus usos
ECSP088508A (es) Antagonistas de neuropilina
DE60332355D1 (de) Hla-a24-restringiertes krebsantigenpeptid
GT200600240A (es) Anticuerpos monoclonales anti-trkb y usos de los mismos
ECSP077280A (es) Moduladores de quinasa de pirrolo-piridina
ECSP10010322A (es) Anticuerpos contra el virus de la influenza y métodos de uso de los mismos
ECSP13012784A (es) Anticuerpos anti-mesotelina e inmunoconjugados
BR112015020804A2 (pt) dispositivo fototerapeutico, método e uso
CR8690A (es) Foliculo estimulador de la hormona supergonists
AR060978A1 (es) Anticuerpos e inmunoconjugados y sus usos
CR10314A (es) Compuestos que tienen actividad en el receptor m 1 y sus usos en medicina
UY35427A (es) Compuestos y sus usos en la modulación de la hemoglobina
CR10734A (es) Anticuerpos e inmunoconjugados y sus usos
UY35425A (es) Compuestos y sus usos en la modulación de la hemoglobina
PA8600601A1 (es) Ligandos de receptores de cannabinoides y sus usos
CR20120449A (es) Formas de rifaximina y sus usos
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
CR11139A (es) Anticuerpos anti-notch1 nrr y sus metodos de uso
BR122013013162A2 (pt) Uso de rivastigmina para preparar um sistema terapêutico transdérmico (tts)
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
BRPI0515518A (pt) análogos de loxapina e métodos de usos dos mesmos
BRPI0719141A2 (pt) Sistema e método para gerar imagem de câncer de próstata, meio legível por computador, e, usos do sistema e de tomografia óptica difusa
UY32554A (es) Compuestos peptidomiméticos de sulfonamida y usos antivirales de los mismos
GT200700096A (es) Compuestos de pirazolina
CR8700A (es) Hormonas humanas de glicoproteinas superagonistas y sus usos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)